Is Annals of Oncology Indexed in PubMed? Yes, and MEDLINE Is Active
Annals of Oncology is indexed in PubMed and currently indexed for MEDLINE, which matters because broad oncology papers need to reach clinicians, trialists, and translational readers.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: yes. Annals of Oncology is indexed in PubMed, and the NLM Catalog shows that it is currently indexed for MEDLINE.
Direct answer
If you publish in Annals of Oncology, your article is discoverable in PubMed and sits inside the active MEDLINE system used across biomedical and clinical literature.
The NLM record shows:
- publication under this title beginning in 1990
- PubMed coverage from volume 1, issue 1
- MEDLINE coverage from volume 1, issue 1
- current indexing status: Currently indexed for MEDLINE
- current subset: Index Medicus
That is a clean, high-confidence indexing record for a flagship oncology journal.
Why this matters for Annals of Oncology
This is not a niche title whose papers only circulate among a small specialist group. The strongest Annals of Oncology papers are meant to reach:
- medical oncologists
- translational oncology researchers
- biomarker and diagnostics readers
- trialists
- review and guideline authors
Those readers often discover papers through disease, biomarker, therapy, and endpoint searches rather than by browsing a specific issue. PubMed visibility is part of how an Annals paper enters real oncology workflows.
PubMed versus MEDLINE
For this page, the answer is yes to both, but the distinction still helps:
- PubMed tells you the article will surface in the main biomedical search tool many oncology readers use first.
- MEDLINE tells you the journal is inside the curated NLM journal index rather than merely surfacing incidentally.
For a journal that aims to influence broad oncology interpretation, both matter.
What indexing does and does not tell you
This page answers the discoverability question. It does not answer the harder submission question.
PubMed indexing tells you that a published paper will be visible in the biomedical literature system. It does not tell you whether the manuscript is broad enough, consequential enough, or mature enough for an Annals of Oncology audience.
That is why the more useful next reads are:
- Is Annals of Oncology a good journal?
- Annals of Oncology submission guide
- Annals of Oncology submission process
- Annals of Oncology acceptance rate
Practical verdict
Yes, Annals of Oncology is indexed in PubMed and currently indexed for MEDLINE. If your question is discoverability, the answer is straightforward.
If your real question is whether the paper belongs in Annals of Oncology, that is a separate fit judgment. A free Manusights scan is the best next step if you want that call before submitting.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.